Guillermo Albericio

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Functional characteristics of plitidepsin as an antiviral treatment against monkeypox virus infection.

Functional characteristics of plitidepsin as an antiviral treatment against monkeypox virus infection.

Journal: Antiviral research
Published: March 18, 2025

Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection.

Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection.

Journal: Cell
Published: January 30, 2025

Development of a Bmi1+ Cardiac Mouse Progenitor Immortalized Model to Unravel the Relationship with Its Protective Vascular Endothelial Niche.

Development of a Bmi1+ Cardiac Mouse Progenitor Immortalized Model to Unravel the Relationship with Its Protective Vascular Endothelial Niche.

Journal: International journal of molecular sciences
Published: July 03, 2024

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.

Journal: Frontiers in immunology
Published: April 19, 2024

Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection.

Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection.

Journal: Antiviral research
Published: July 27, 2023

Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.

Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.

Journal: Frontiers in immunology
Published: July 20, 2023

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 16, 2023

Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress.

Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress.

Journal: Cells
Published: July 08, 2023

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.

Journal: Journal of molecular biology
Published: March 02, 2023

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Journal: Frontiers in immunology
Published: February 23, 2023

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.

Journal: Frontiers in immunology
Published: February 10, 2023

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Journal: Frontiers in immunology
Published: September 14, 2022
Showing 1-12 of 19

Last Updated: 09/26/2026